ResearcherJohns Hopkins UniversityNo recent work listed
Neda Rezaee
Matched on ORCID iD 0000-0002-2016-5908; OpenAlex author ID A5077604478. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2015: 3 papers · 2016: 2 papers · 2017: 2 papers · 2018: 2 papers
Papers 9
- Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conven… Co-author DOI 10.1016/j.surg.2017.11.027↗
- Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/sla.0000000000002234↗
- Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-017-5864-9↗
- Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival. Co-author DOI 10.21037/hbsn.2016.08.06↗
- Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2015.10.010↗
- Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0164195↗
- What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? Co-author DOI 10.1007/s11605-014-2740-9↗
- Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcop… Co-author DOI 10.1007/s11605-015-2835-y↗
- Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis. Co-author DOI 10.1158/1078-0432.ccr-14-2600↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher Lee Wolfgang · 9 shared papers, 2015–2018 · strength 0.53
- Paper Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002234↗
- Paper Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact… DOI 10.1016/j.surg.2017.11.027↗
- Paper Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with i… DOI 10.21037/hbsn.2016.08.06↗
- Matthew John Weiss · 7 shared papers, 2015–2018 · strength 0.43
- Paper Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002234↗
- Paper Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact… DOI 10.1016/j.surg.2017.11.027↗
- Paper Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with i… DOI 10.21037/hbsn.2016.08.06↗
- Ralph H. Hruban · 7 shared papers, 2015–2018 · strength 0.41
- Paper Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002234↗
- Paper Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact… DOI 10.1016/j.surg.2017.11.027↗
- Paper Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenoc… DOI 10.1245/s10434-017-5864-9↗
- Jin Peng He · 6 shared papers, 2015–2018 · strength 0.38
- Paper Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002234↗
- Paper Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact… DOI 10.1016/j.surg.2017.11.027↗
- Paper Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with i… DOI 10.21037/hbsn.2016.08.06↗
- Lei Zheng · 3 shared papers, 2015–2018 · strength 0.20
- Paper Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002234↗
- Paper Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact… DOI 10.1016/j.surg.2017.11.027↗
- Paper What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcin… DOI 10.1007/s11605-014-2740-9↗
- Joseph M. Herman · 3 shared papers, 2015–2018 · strength 0.17
- Paper Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact… DOI 10.1016/j.surg.2017.11.027↗
- Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
- Paper What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcin… DOI 10.1007/s11605-014-2740-9↗
- Amanda L. Blackford · 3 shared papers, 2015–2017 · strength 0.16
- Paper Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenoc… DOI 10.1245/s10434-017-5864-9↗
- Paper Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1371/journal.pone.0164195↗
- Paper Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results o… DOI 10.1158/1078-0432.ccr-14-2600↗
- Marco Dal Molin · 3 shared papers, 2015–2017 · strength 0.16
- Paper Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenoc… DOI 10.1245/s10434-017-5864-9↗
- Paper Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1371/journal.pone.0164195↗
- Paper Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results o… DOI 10.1158/1078-0432.ccr-14-2600↗
- Timothy Michael Pawlik · 3 shared papers, 2015–2017 · strength 0.16
- Paper Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with i… DOI 10.21037/hbsn.2016.08.06↗
- Paper Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Ade… DOI 10.1007/s11605-015-2835-y↗
- Paper What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcin… DOI 10.1007/s11605-014-2740-9↗
- Elliot K. Fishman · 2 shared papers, 2015–2018 · strength 0.12
- Paper Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002234↗
- Paper What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcin… DOI 10.1007/s11605-014-2740-9↗
- Michael Goggins · 2 shared papers, 2016–2017 · strength 0.12
- Paper Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenoc… DOI 10.1245/s10434-017-5864-9↗
- Paper Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1371/journal.pone.0164195↗
- Laura DeLong Wood · 2 shared papers, 2015–2016 · strength 0.10
- Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
- Paper Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results o… DOI 10.1158/1078-0432.ccr-14-2600↗
- Vincent P. Groot · 1 shared paper, 2018 · strength 0.08
- Wenchuan Wu · 1 shared paper, 2018 · strength 0.08
- Lauren M. Rosati · 1 shared paper, 2018 · strength 0.08
- Georgios Gemenetzis · 1 shared paper, 2018 · strength 0.08
- Alex B. Blair · 1 shared paper, 2018 · strength 0.08
- Kevin C. Soares · 1 shared paper, 2017 · strength 0.07
- Fengchun Lu · 1 shared paper, 2017 · strength 0.07
- Ammar A. Javed · 1 shared paper, 2017 · strength 0.07
- Jun Yu · 1 shared paper, 2017 · strength 0.06
- Koji Shindo · 1 shared paper, 2016 · strength 0.06
- James F. Griffin · 1 shared paper, 2016 · strength 0.06
- Bülent Salman · 1 shared paper, 2016 · strength 0.05
- Nita Ahuja · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.